International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Hazel

Oon

,

MD, MRCP, MMed Internal Medicine

Chief
National Skin Centre
Singapore
,
Singapore
Councilor Since: October 3, 2023
IPC Councilor
Request an Update
Dr. Hazel Oon heads the Psoriasis Unit and Acne Clinic at the National Skin Centre, Singapore. She obtained her medical degree from the University of Toronto. Dr. Oon serves as Medical Advisor to the Psoriasis Association of Singapore, Regional Coordinator for the Global Psoriasis Atlas (GPA), Chair of the Chapter of Dermatologists in Singapore 2023 – 2025, Skin Research Institute of Singapore (SRIS) scientist, and Executive Committee Member of the Skin Research Society of Singapore. She is also the Clinical Educator Lead for undergraduate dermatology in the three medical schools in Singapore, Principal Lead for dermatology at the Lee Kong Chian School of Medicine, and Clinical Lecturer for the Yong Loo Lin School of Medicine. Dr. Oon is the principal investigator in several Phase III biologic trials on psoriasis and hidradenitis and has authored guidelines on psoriasis, acne, and rosacea. Her areas of interest are psoriasis, acne, hidradenitis suppurativa, rosacea, and photo dermatology.
Last Updated:
10/24/2023

Areas of Interest

Metabolic comorbidities, including steatotic liver disease Team-based care; Women’s dermatology; Medical education Improving access to psoriasis care and research in the Asian region

IPC Committees / Groups

Asia-Pacific Region Steering Committee, Research Committee

Involvement with Other Organization(s)

Medical Advisor to the Psoriasis Association of Singapore, Regional Coordinator for South Asia for the Global Psoriasis Atlas, Chair of the Chapter of Dermatologists in Singapore 2023 – 2025, undergraduate dermatology lead for medical schools in Singapore.
Recent publications

Featured

Blog

Meet Our Newest IPC Councilors: Experts in Psoriasis Care and Research.

Join us in welcoming Irène Gallais Sérézal, Hazel Oon, Dharshini Sathishkumar, and Yu Sawada as they bring their…

Read More

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026